40
Participants
Start Date
March 7, 2025
Primary Completion Date
July 30, 2025
Study Completion Date
January 1, 2026
iEV
Intranasal administration of iEV, twice a week, 2 ml each time (at a concentration of 2×10¹⁰/ml), for 12 consecutive weeks.
Basic treatments
Basic treatments for cerebrovascular diseases such as antiplatelet aggregation, blood pressure control, blood glucose control, blood lipid control, and plaque stabilization.
RECRUITING
Shanghai Sixth People's Hospital, Shanghai
Hongmei Wang
OTHER